Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease

Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease

US Patent 12421240 · Granted Sep 23, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triazatricycle compounds for the treatment of autoimmune disease2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepati2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepati2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025
Tricyclic compounds for the treatment of cancer2025
Human alpha fetoprotein-specific t cell receptors and uses thereof2024
Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of 2024